TrialClinical cancer research : an official journal of the American Association for Cancer Research2020

Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer.

Takahiro Tsujikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.